EURION, European Cluster to Improve Identification of Endocrine Disruptors, kindly asks for your input to an initial general review of stakeholders’ interests, needs and priorities in relation to the development of endocrine disruptor (ED) test methods: participate here.
ERGO is one of eight European research projects that are part of the EURION Cluster (www.eurion-cluster.eu), funded by the European Union’s Horizon 2020 research and innovation programme. The projects are focusing on the development of new ED test methods targeting relevant endpoints that are not sufficiently covered by current regulatory tests.
Stakeholders are invited to contribute their opinion on what criteria should be considered the most important for the development of these test methods. Your contribution will be critical to inform EURION, and ultimately to the development of new tests that are urgently needed for hazard assessment of EDs in Europe.
The results of this consultation will be presented and discussed at an EURION Stakeholder Workshop planned to take place on 11 December 2020, more details will be confirmed soon.
Please note all data provided in the consultation will be handled in accordance with the General Data Protection Regulation (GDPR) (EU 2016/679). The results of the consultation will be presented anonymously. By participating in and submitting this consultation, participants confirm they have read this information and agree that the information provided within the consultation may be used for EURION purposes, including presentations and exchange among relevant stakeholders as well as potential related materials, published papers and reports.
Please answer the short (5-10 min) questionnaire by 15 OCTOBER 2020: PARTICIPATE HERE
For more information contact the ENDpoiNTs and ERGO Coordination 2020-2021 Team:
Joëlle Rüegg (ENDpoiNTS)
Henrik Holbech (ERGO)
EURION Communication and Press:
Avril Hanbidge (ERGO)